corporate governance

  • H World Group Limited Announces Board Composition Changes

    H World Group (HTHT) announced Board of Directors changes effective August 15, 2025. Justin Martin Leverenz, ex-CIO at Invesco Developing Markets Fund, joins as a director. Yi Zhang (Bonnie Yi Zhang), SINA Corporation’s CFO, becomes an independent director and Audit Committee chairwoman. Lei Cao joins the Compensation Committee. Tong Tong Zhao transitions to Board observer. Jian Shang departs from independent director and committee roles. These changes aim to bolster H World’s strategic growth with diverse financial and emerging market expertise.

    6 days ago
  • LZG International, Inc. Shareholders to Hold Special Meeting

    LZG International (OTC: LZGI) will hold a special shareholder meeting on August 18, 2025, in Miami and virtually, initiated by shareholders representing over 10% of shares. Key agenda items include electing a new Board of Directors, evaluating audit candidates, and securing corporate assets and data systems. Shareholders must display name and share count for access; proxy voting is available. The meeting signals potential governance concerns and a push for change.

    2025年8月13日
  • Chairman of Nanning Company Only 17: Official Response Affirms Legality

    Nanning Yunguitong Technology faces a social media controversy in China over its young leadership, including a 17-year-old Chairman. The company defends its executive’s eligibility under Chinese Civil Code Article 18, which grants full civil capacity to employed minors aged 16+. Yunguitong asserts compliance with all regulations, emphasizing that registration details are accurate and its objectives align with legitimate, socially responsible business activities. The company also participates in the China International College Students’ Innovation Competition.

    2025年8月11日
  • TotalEnergies SE: Disclosure of Voting Rights and Share Capital as of July 31, 2025

    TotalEnergies SE (TTE) announced its voting rights and share capital figures as of July 31, 2025. The disclosure, mandated by French regulations, details the total number of shares, theoretical voting rights, and exercisable voting rights. These figures are essential for investors to assess their voting power, understand shareholder influence, and monitor potential shifts in corporate structure, particularly amidst TotalEnergies’ strategic evolution and investments in renewable energy. Analysts suggest investors carefully review this data alongside other financial information.

    2025年8月9日
  • 5 Bosses Flee to Malaysia: Romoss Grapples with $50M Inventory, Skeleton Staff

    Power bank manufacturer Romoss is facing a severe financial crisis following a recent product incident, with estimated monthly losses of 100-200 million yuan. Reports indicate a significantly reduced workforce, large amounts of idle inventory, and employee/supplier protests outside the Shenzhen headquarters. Senior management is reportedly “disappeared” and core executives allegedly fled to Malaysia. Romoss issued a work stoppage notice, claiming after-sales services would continue, but these claims are disputed. The company’s legal representative has changed multiple times recently, raising governance concerns.

    2025年7月21日
  • Correction Notice for Ridgeline Minerals Annual General Meeting

    Ridgeline Minerals (RDGMF) has corrected a typographical error in its upcoming Annual General Meeting (AGM) materials, clarifying the record date as July 3, 2025. The AGM is still scheduled for August 12, 2025. Amended materials are available on SEDAR+ and the company website. Ridgeline Minerals focuses on exploration across seven projects in Nevada, holding both wholly-owned assets and strategic partnerships.

    2025年7月16日
  • Findell Recommends Oportun Stockholders Vote FOR Warren Wilcox, WITHHOLD on CEO Raul Vazquez

    Institutional Shareholder Services (ISS) supports Findell Capital’s push for board changes at Oportun’s 2025 meeting, citing poor governance and underperformance. ISS recommends voting for Findell’s nominee, Warren Wilcox, and withholding votes from CEO Raul Vazquez, who is blamed for a 55% stock decline since the IPO. ISS highlights Oportun’s value-destructive strategic pivot, governance misalignments, and board independence concerns, advocating for Wilcox’s experienced oversight.

    2025年7月7日
  • Benchmark Appoints Glynis A. Bryan to Board of Directors

    Benchmark Electronics appoints Glynis A. Bryan, former CFO of Insight Enterprises, to its Board of Directors. Bryan brings over 20 years of financial experience, including strategic growth and M&A expertise. She also serves on the boards of Ameriprise Financial, Pinnacle West Capital, and WESCO International. Benchmark’s leadership welcomes her financial acumen and strategic oversight to enhance decision-making and long-term goals.

    2025年6月19日
  • MINISO Group Announces Annual General Meeting Results

    MINISO Group (MNSO) successfully held its annual general meeting in Hong Kong on June 12, 2025, with shareholders approving all resolutions. This crucial event reaffirms MINISO’s commitment to strong corporate governance and shareholder engagement. The positive outcome boosts investor confidence in the company’s sustainable growth and its position in the global retail market.

    2025年6月12日
  • Alvotech Schedules Annual General Meeting for June 25, 2025

    Alvotech (NASDAQ: ALVO) will hold its 2025 Annual General Meeting on June 25 in Reykjavik, with virtual access available. Shareholders will review governance updates, financial results, and strategies to bolster its position in the biosimilars market, projected to yield $50 billion in global savings by 2027. Key discussions include expanding its biosimilar pipeline, regulatory progress in the U.S. and Europe, and addressing pricing challenges and patent cliffs. Analysts highlight priorities like commercial partnerships, scalable manufacturing, and differentiation in immunology and oncology. The meeting may signal strategic shifts as Alvotech navigates evolving FDA regulations and leverages biosimilars to counter pharmaceutical revenue declines, emphasizing speed-to-market and cost efficiency.

    2025年5月26日